Latest & greatest articles for postnatal depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on postnatal depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on postnatal depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for postnatal depression

1. Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial Full Text available with Trip Pro

Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial Telephone-based Nurse-Delivered Interpersonal Psychotherapy for Postpartum Depression: Nationwide Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health (...) Permalink Copy Page navigation Br J Psychiatry Actions . 2020 Apr;216(4):189-196. doi: 10.1192/bjp.2019.275. Telephone-based Nurse-Delivered Interpersonal Psychotherapy for Postpartum Depression: Nationwide Randomised Controlled Trial , , , , Affiliations Expand Affiliations 1 Professor, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto; Women's Health Research Chair, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Canada. 2 Associate Professor of Psychiatry, Department

2020 EvidenceUpdates

2. Effect of couple-based cognitive behavioural intervention on prevention of postnatal depression: multisite randomised controlled trial (Abstract)

CBI (n = 134), women-alone CBI (n = 124) or control (n = 130). The CBI consists of a 3-hour antenatal group session and two 30-minute postnatal telephone follow-up sessions.The primary outcome was depressive symptoms, measured on the Edinburgh Postnatal Depression Scale (EPDS). Assessments were collected at baseline (during pregnancy), 6 weeks, 6 months, and 12 months postpartum.Depressive symptoms were significantly more improved at 6 weeks postpartum for mothers in couple-based CBI than in women (...) -alone CBI (difference 1.46, 95% CI 0.11-2.81) or control groups (difference 1.71, 95% CI 0.29-3.13). The proportion of mothers with postnatal depression (EPDS score ≥ 10) was significantly lower at 6 weeks postpartum in couple-based CBI than in control (difference 17.8%, 95% CI 3.6-32.0). However, the treatment effect was not maintained at 6 and 12 months. There was no significant intervention effect among fathers.Couple-based CBI is more effective than CBI delivered to mothers alone and standard

2019 EvidenceUpdates

3. Brexanolone (Zulresso) - To treat postpartum depression (PPD)

Brexanolone (Zulresso) - To treat postpartum depression (PPD) Drug Approval Package: Zulresso U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: Zulresso Company: Sage Therapeutics, Inc. Application Number: 211371 Approval Date: 03/19/2019 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF) (PDF) FDA Application Review Files (PDF) (PDF) (PDF) (PDF) (PDF

2019 FDA - Drug Approval Package

4. Postnatal depression

Postnatal depression Postnatal depression - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Postnatal depression Last reviewed: February 2019 Last updated: February 2019 Summary Refers to the development of a depressive illness following childbirth and may form part of a unipolar or, less frequently, a bipolar illness. The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) does not recognise (...) postnatal depression as a separate diagnosis; rather, patients must meet the criteria for a major depressive episode and the criteria for the perinatal-onset specifier. The definition according to DSM-5 is, therefore, a major depressive episode with an onset in pregnancy or within 4 weeks of delivery. However there is no established consensus as to the length of postnatal period, and some authorities define postnatal depression as occurring within the first 12 months after delivery. Aetiology is poorly

2019 BMJ Best Practice

5. Efficacy of Regular Exercise During Pregnancy on the Prevention of Postpartum Depression: The PAMELA Randomized Clinical Trial Full Text available with Trip Pro

via computer-generated randomization using a block size of 9. Data were analyzed from March 7 to May 2, 2018.Participants assigned to the intervention were engaged in a 16-week supervised exercise program including aerobic and resistance training delivered in 60-minute sessions 3 times per week.Postpartum depressive symptoms were assessed with the Edinburgh Postnatal Depression Scale 3 months after birth. A score of 12 or greater was defined as screening positive for postpartum depression. Primary (...) Efficacy of Regular Exercise During Pregnancy on the Prevention of Postpartum Depression: The PAMELA Randomized Clinical Trial Interventions to reduce postpartum depression have mainly focused on enhancing screening to increase treatment rates among women. Preventive approaches are timely from a population health perspective, particularly in low- and middle-income countries where access to mental health services is limited.To assess the efficacy of regular exercise during pregnancy

2019 EvidenceUpdates

6. Women’s health and midwifery: Training health visitors in cognitive behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression Full Text available with Trip Pro

Women’s health and midwifery: Training health visitors in cognitive behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression Training health visitors in cognitive behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie (...) behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression Article Text Commentary Women’s health and midwifery Training health visitors in cognitive behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression Ben Parkinson , Emma MacDonald Statistics from Altmetric.com Commentary on: Henderson C, Dixon S, Bauer A. et al . Cost-Effectiveness of PoNDER Health Visitor Training

2019 Evidence-Based Nursing

7. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. (Abstract)

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Post-partum depression is associated with substantial morbidity, and improved pharmacological treatment options are urgently needed. We assessed brexanolone injection (formerly SAGE-547 injection), a positive allosteric modulator of γ-aminobutyric-acid type A (GABAA) receptors, for the treatment of moderate to severe post-partum depression.We did two double-blind (...) , randomised, placebo-controlled, phase 3 trials, at 30 clinical research centres and specialised psychiatric units in the USA. Eligible women were aged 18-45 years, 6 months post partum or less at screening, with post-partum depression and a qualifying 17-item Hamilton Rating Scale for Depression (HAM-D) score (≥26 for study 1; 20-25 for study 2). Women with renal failure requiring dialysis, anaemia, known allergy to allopregnanolone or to progesterone, or medical history of schizophrenia, bipolar

2018 Lancet Controlled trial quality: predicted high

8. Postnatal depression

and value of information analysis Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis Hewitt CE, Gilbody SM, Brealey S, Paulden M, Palmer S, Mann R, Green J, Morrell J, Barkham M, Light K, Richards D CRD (...) summary This review concluded that the Edinburgh Postnatal Depression Scale was a precise and validated test for identifying post-natal depression . There was insufficient evidence that use of identification strategies (...) women with postnatal depression ? 2. What are the experiences and perceptions of stigma among women who have postnatal depression ? 3. What interventions aiming to reduce stigma among women with postnatal 2017 7. The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale. BACKGROUND: Universal screening for postpartum depression is recommended in many countries. Knowledge of whether the disclosure of depressive

2018 Trip Latest and Greatest

9. Postpartum depression

Postpartum depression Evidence Maps - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4

2018 Trip Evidence Maps

10. Effect of singing interventions on symptoms of postnatal depression: three-arm randomised controlled trial Full Text available with Trip Pro

Effect of singing interventions on symptoms of postnatal depression: three-arm randomised controlled trial This study assessed whether a novel psychosocial intervention could reduce symptoms of postnatal depression (PND) in the first 40 weeks post-birth. Analyses were carried out of 134 mothers with symptoms of PND randomised into 10 weeks of group singing workshops or group play workshops for them and their babies, or usual care (trial registration: NCT02526407). Overall, among all mothers

2018 EvidenceUpdates

11. Antidepressants for preventing postnatal depression. Full Text available with Trip Pro

nortriptyline with placebo and did not find any evidence that nortriptyline was effective in preventing postnatal depression. In this study, 23% (6/26) of women who took nortriptyline and 24% (6/25) of women who took placebo experienced postnatal depression (RR 0.96, 95% CI 0.36 to 2.59, very low quality evidence) in the first 17 weeks postpartum. One woman taking nortriptyline developed mania; and one side effect, constipation, was more common among women taking nortriptyline than those taking placebo.The (...) second study compared sertraline with placebo. In this study, 7% (1/14) of women who took sertraline developed postnatal depression in the first 17 weeks postpartum compared with 50% (4/8) of women who took placebo. It is uncertain whether sertraline reduces the risk of postnatal depression (RR 0.14, 95% CI 0.02 to 1.07, very low quality evidence). One woman taking sertraline had a hypomanic episode. Two side effects (dizziness and drowsiness) were more common among women taking sertraline than women

2018 Cochrane

12. Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004–2015 Full Text available with Trip Pro

Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004–2015 Postpartum depression is a mood disorder that commonly affects women during the early postpartum period. The objective of this study was to analyse the association of postpartum depression with drugs (including contraceptive devices and implants) with spontaneously reported adverse events reported in the US Food and Drug (...) Administration Adverse Event Reporting System database.Retrospective study.Reports of postpartum depression events between 2004-2015 were analysed with a reporting odds ratio (ROR) algorithm. The Medical Dictionary for Regulatory Activities was used to identify postpartum depression.The reporting odds ratios (95% confidence intervals, CI) of levonorgestrel (an intrauterine device with progestogen), etonogestrel (a hormonal contraceptive implant), sertraline and drospirenone (an oral contraceptive) were 12.5

2018 Nursing open

13. Postnatal depression

Postnatal depression Postnatal depression - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Postnatal depression Last reviewed: February 2019 Last updated: February 2019 Summary Refers to the development of a depressive illness following childbirth and may form part of a unipolar or, less frequently, a bipolar illness. The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) does not recognise (...) postnatal depression as a separate diagnosis; rather, patients must meet the criteria for a major depressive episode and the criteria for the perinatal-onset specifier. The definition according to DSM-5 is, therefore, a major depressive episode with an onset in pregnancy or within 4 weeks of delivery. However there is no established consensus as to the length of postnatal period, and some authorities define postnatal depression as occurring within the first 12 months after delivery. Aetiology is poorly

2018 BMJ Best Practice

14. Depression - antenatal and postnatal

of mental health problems developing during pregnancy or the postnatal period is different from those occurring at other times of life. If depression is untreated during pregnancy, women have a seven-fold increased risk of postpartum depression compared with women with no antenatal depressive symptoms. Depression occurring postnatally is often self-limiting within a few months, however about one third of women are still unwell one year after childbirth, and about 13% after 2 years. The risk (...) month, have you often been bothered by having little interest or pleasure in doing things? Regularly ask women about their current mental health during pregnancy and the postpartum period. Postnatally, ask about emotional wellbeing and whether symptoms of baby blues such as low mood, tearfulness, and anxiety have resolved at 10–14 days after birth. If depression is suspected from a positive answer to either of the depression identification questions, the woman is at risk of developing a mental

2018 NICE Clinical Knowledge Summaries

15. The effectiveness of mindfulness training on reducing the symptoms of postpartum depression Full Text available with Trip Pro

The effectiveness of mindfulness training on reducing the symptoms of postpartum depression Postpartum depression is one of the prevalent disorders among new mothers. The present research aimed to examine the effectiveness of mindfulness training on reducing the symptoms of postpartum depression.The present quasi-experimental research was conducted on 410 new mothers in Shahid Chamran Hospital, Tehran in 2014. Using the Beck Depression Inventory (BDI), Structured Clinical Interview (...) -test were significant (p<0.001), compared to those for the control group. Also, it was revealed that pre- and posttest mean scores for postpartum depression in the control group were 25.81 and 25.12 respectively while the scores for the experimental group were 24.75 and 18.5 respectively. Since the posttest mean score in the experimental group was lower than that in the pretest, it can be said that the treatment, i.e., mindfulness training, was effective in reducing depression symptoms

2017 Electronic physician Controlled trial quality: uncertain

16. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. (Abstract)

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Post-partum depression is a serious mood disorder in women that might be triggered by peripartum fluctuations in reproductive hormones. This phase 2 study investigated brexanolone (USAN; formerly SAGE-547 injection), an intravenous formulation of allopregnanolone, a positive allosteric modulator of γ-aminobutyric acid (GABAA) receptors, for the treatment of post-partum depression.For this double-blind (...) , randomised, placebo-controlled trial, we enrolled self-referred or physician-referred female inpatients (≤6 months post partum) with severe post-partum depression (Hamilton Rating Scale for Depression [HAM-D] total score ≥26) in four hospitals in the USA. Eligible women were randomly assigned (1:1), via a computer-generated randomisation program, to receive either a single, continuous intravenous dose of brexanolone or placebo for 60 h. Patients and investigators were masked to treatment assignments

2017 Lancet Controlled trial quality: predicted high

17. Systematic review with meta-analysis: Psychological treatment is one of the several important components to the effective management of postpartum depression

depression Article Text Women's health and midwifery Systematic review with meta-analysis Psychological treatment is one of the several important components to the effective management of postpartum depression Cindy-Lee Dennis Statistics from Altmetric.com Commentary on : Stephens S , Ford E , Paudy P , et al . Effectiveness of psychological interventions for postnatal depression in primary care: a meta-analysis . Implications for practice and research Psychological treatments can be delivered in primary (...) Systematic review with meta-analysis: Psychological treatment is one of the several important components to the effective management of postpartum depression Psychological treatment is one of the several important components to the effective management of postpartum depression | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies

2017 Evidence-Based Nursing

19. A brief group intervention using a cognitive-behavioural approach to reduce postnatal depressive symptoms: a randomised controlled trial. (Abstract)

Centre for Nursing Studies, National University of Singapore. Chung K F KF Department of Psychiatry, The University of Hong Kong. eng Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't China Hong Kong Med J 9512509 1024-2708 IM Adult Cognitive Behavioral Therapy methods Depression, Postpartum therapy Female Hong Kong Humans Postnatal Care Postpartum Period psychology Psychiatric Status Rating Scales Psychotherapy, Group methods Socioeconomic Factors Treatment Outcome Young (...) A brief group intervention using a cognitive-behavioural approach to reduce postnatal depressive symptoms: a randomised controlled trial. 26908335 2016 12 13 2018 12 02 1024-2708 22 Suppl 2 2016 Feb Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J A brief group intervention using a cognitive-behavioural approach to reduce postnatal depressive symptoms: a randomised controlled trial. S4-8 Leung S S K SS Institute of Professional Education, Hong Kong Baptist Hospital. Lee A M

2016 Hong Kong medical journal = Xianggang yi xue za zhi Controlled trial quality: predicted high

20. The Relation of Pre and Postnatal Depression and Anxiety with Exclusive Breastfeeding Full Text available with Trip Pro

The Relation of Pre and Postnatal Depression and Anxiety with Exclusive Breastfeeding Studies on the relationship between prenatal psychosocial risk factors and breastfeeding are disjointed. Maternal health status has a great influence on breastfeeding, growth, and general health of the neonates. The aim of this study was to ascertain the relation between maternal mental health and breastfeeding status of mothers in Kazerun (Fars province, Iran).This cross-sectional study was conducted (...) on a total of 92 pregnant women recruited from clinics in Kazerun in 2015. Participants were divided into two groups subject to exclusive breastfeeding. Spielberger Anxiety Inventory, Beck Depression Inventory and Edinburgh Postnatal Depression Scale (EPDS) were used for data collection. Data analysis was performed by the SPSS version 16 using descriptive statistics, Chi-square, and Fisher's exact test.The average of state anxiety score according to Spielberger Anxiety Inventory was 1.97±0.51

2016 Electronic physician